#Oncoalert

世界中の人々によるOncoalertに関する件のリール動画を視聴。

ログインせずに匿名で視聴。

トレンドリール

(12)
#Oncoalert Reel by @oncoalert - 🌐 Big news: The 6th OncoAlert 🚨Colloquium is NOW AVAILABLE IN YOUR LANGUAGE!! ALL VIDEOS HERE 👇👇https://oncoalert360.com/multi-language127760coll
959
ON
@oncoalert
🌐 Big news: The 6th OncoAlert 🚨Colloquium is NOW AVAILABLE IN YOUR LANGUAGE!! ALL VIDEOS HERE 👇👇https://oncoalert360.com/multi-language127760colloquium.html 🇪🇸🇮🇳🇵🇹🇮🇹🇫🇷🇺🇦🇯🇵🇲🇽🇸🇦🇷🇺and many more SPOKEN & WITH CAPTIONS in 1⃣8⃣Languages Top oncology experts. Global reach. Zero barriers. Watch the 50-sec video to learn how!! @elisabetta_bonzano @eli_agoss @drjosefernandomoura @natalia.gandur @kristina_jankovic @matteo.lambertini @evandretto @esgo.society @agz_eriksson @_i_c_r_o_ @essonews @barbaramelao_urologia @lucarecco @ENYGO @nico.bizza @aleksandra_strojna @gerry.hanna @fadihaddadmd @_i_c_r_o_ @drsgraff
#Oncoalert Reel by @oncoalert - The OncoAlert🚨Newsletter Covering March 20-26, 2026 REGISTER TO GET IT 👉 https://buff.ly/7Jlzp0V or www.OncoAlert360.com 🚨 This week's Spotlight
3.5K
ON
@oncoalert
The OncoAlert🚨Newsletter Covering March 20-26, 2026 REGISTER TO GET IT 👉 https://buff.ly/7Jlzp0V or www.OncoAlert360.com 🚨 This week’s Spotlight is all about trials making waves 🔵 CALYPSO – Savolitinib + durvalumab in papillary renal cancer 🧬 TAILORx – AI validation for breast cancer recurrence prediction 💊 RAGNAR & LUC2001 – Erdafitinib in FGFR-altered cholangiocarcinoma 🟢 RECAST (WJOG9216G) – FOLFIRI vs FOLFOXIRI + ramucirumab in mCRC 🫁 TROPION-Lung02 – Dato-DXd + pembrolizumab in advanced NSCLC 🎯 ORCHARD – Durvalumab + chemo post-osimertinib in EGFR-mutated NSCLC Join nearly 10,000 oncology colleagues — with a 55–60% weekly open rate — and stay up to date with the latest in oncology. @elisabetta_bonzano @eli_agoss @drjosefernandomoura @natalia.gandur @kristina_jankovic @matteo.lambertini @evandretto @esgo.society @agz_eriksson @_i_c_r_o_ @essonews #ELCC26 #EBCC15
#Oncoalert Reel by @oncoalert - The #OncoAlertColloquium 2026 GI Malignancies🚨 DAY THREE Presentation by Dr. Erman Akkus🇹🇷 of Ankara University: How I treat GI Cancers with Limite
682
ON
@oncoalert
The #OncoAlertColloquium 2026 GI Malignancies🚨 DAY THREE Presentation by Dr. Erman Akkus🇹🇷 of Ankara University: How I treat GI Cancers with Limiter Resources REGISTER HERE TO WATCH: https://buff.ly/xwD5G2D A real-world, practice-focused discussion on delivering high-quality care when access is constrained, covering: 🔹 Colorectal & Anal Cancer 🔹 Esophageal & Gastric Cancer 🔹 Hepatocellular Carcinoma 🔹 Pancreatic & Biliary Cancers An important perspective on prioritization, adaptation, and evidence-based decision-making in resource-limited settings. 💡 @barbaramelao_urologia @elisabetta_bonzano @eli_agoss @drjosefernandomoura @natalia.gandur @kristina_jankovic @gaiagriguolo @alizee_c_m @matteo.lambertini @lucarecco @evandretto @maryamlustberg_md
#Oncoalert Reel by @oncoalert - The OncoAlert🚨Newsletter Covering March 12-19, 2026 REGISTER TO GET IT 👉 https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registration or
5.9K
ON
@oncoalert
The OncoAlert🚨Newsletter Covering March 12-19, 2026 REGISTER TO GET IT 👉 https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registration or www.OncoAlert360.com 🚨 This week’s Spotlight is all about trials making waves 🔬 DESTINY-Breast08 takes center stage — exploring T-DXd combinations in HER2-low mBC with impressive early activity ➕ Also in the mix: 🧬 FOURLIGHT-1 – next-gen CDK4 inhibitor momentum 🍽️ MATTERHORN – perioperative immunotherapy changing GI standards 📩 Plus: cutting-edge science across breast, lung, GI, and GU malignancies Join nearly 10,000 oncology colleagues — with a 55–60% weekly open rate — and stay up to date with the latest in oncology. @elisabetta_bonzano @eli_agoss @drjosefernandomoura @natalia.gandur @kristina_jankovic @matteo.lambertini @evandretto @esgo.society @agz_eriksson @_i_c_r_o_ @essonews
#Oncoalert Reel by @oncoassist - Hear from Dr Akash Maniam as he shares why this ONCO-IQ on Genitourinary cancers, developed in collaboration with @urologysummit , cannot be missed!
323
ON
@oncoassist
Hear from Dr Akash Maniam as he shares why this ONCO-IQ on Genitourinary cancers, developed in collaboration with @urologysummit , cannot be missed! Take the poll question below and access the full quiz here: 🔗Link in Bio🔗 #genitourinary #guoncology #bladdercancer #prostatecancer #oncologyresearch [Oncology Tool, Oncology App, ONCOassist, Oncology Quiz, Gentourinary Cancers Quiz]
#Oncoalert Reel by @onclive - 👀 Watch: Arshed Al-Obeidi, MD, unpacks an analysis of the UC Genome Study focused on the effects alternative splicing on outcomes in metastatic bladd
385
ON
@onclive
👀 Watch: Arshed Al-Obeidi, MD, unpacks an analysis of the UC Genome Study focused on the effects alternative splicing on outcomes in metastatic bladder cancer during the OncLive National Fellows Forum on genitourinary cancers. #oncology #ASCOGU2026
#Oncoalert Reel by @oncoalert - The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 2 #GU26 Presentation by Dr. Tom Powles: Year in Review in #BladderCancer REGISTER HERE TO WATCH: h
576
ON
@oncoalert
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 2 #GU26 Presentation by Dr. Tom Powles: Year in Review in #BladderCancer REGISTER HERE TO WATCH: https://buff.ly/u2B4SNk Tom Powles 2025 year-in-review highlights real progress—and ongoing challenges—in Bladder Cancer @barbaramelao_urologia @elisabetta_bonzano @eli_agoss @drjosefernandomoura @natalia.gandur @kristina_jankovic @gaiagriguolo @alizee_c_m @matteo.lambertini @lucarecco @evandretto @maryamlustberg_md
#Oncoalert Reel by @oncoalert - The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 2 #GU26 Presentation by Dr. Silke Gillessen 🇨🇭 of APCCC: Year in Review #ProstateCancer REGISTER
773
ON
@oncoalert
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 2 #GU26 Presentation by Dr. Silke Gillessen 🇨🇭 of APCCC: Year in Review #ProstateCancer REGISTER HERE TO WATCH: https://buff.ly/FaS5Cb6
#Oncoalert Reel by @oncoalert - The #OncoAlertColloquium 2026 GU Malignancies🚨 #EAU26 Presentation by Dr. Tom Powles: Year in Review in #BladderCancer WATCH HERE👉 https://vimeo.co
484
ON
@oncoalert
The #OncoAlertColloquium 2026 GU Malignancies🚨 #EAU26 Presentation by Dr. Tom Powles: Year in Review in #BladderCancer WATCH HERE👉 https://vimeo.com/1160841460?share=copy&fl=sv&fe=ci Tom Powles 2025 year-in-review highlights real progress—and ongoing challenges—in Bladder Cancer GU Oncology Colloquium Faculty brian_rini 🇺🇸 tompowles1 🇬🇧 declangmurphy 🇦🇺 KidneyCancer🇺🇸 @salvolarosa silkegillessen 🇨🇭 RenuEapen🇦🇺 nataliagandur 🇦🇷 seanmcbride 🇺🇸 DrJaVallejo 🇪🇸 @barbaramelao_urologia @elisabetta_bonzano @eli_agoss @drjosefernandomoura @natalia.gandur @kristina_jankovic @gaiagriguolo @matteo.lambertini @lucarecco @aenizam @gu_cast_podcast @renu.eapen @alvaropintomarin @drenriquegrande @apbello2 @docjavip @mjuanfi81 @kidneycancerassociation @save_therose
#Oncoalert Reel by @oncoalert - Dear Colleagues, OncoAlert 🚨is Proud to be collaborating with @AUC3_Official and will be coming LIVE from Miami🌴 in January for #AUC3 2026 ARTICLE
837
ON
@oncoalert
Dear Colleagues, OncoAlert 🚨is Proud to be collaborating with @AUC3_Official and will be coming LIVE from Miami🌴 in January for #AUC3 2026 ARTICLE HERE: 👉 https://buff.ly/ULensJm Here is one of the co Organizers @DrChoueiri 🇺🇸 To tell us about the #AUC3 publication JUST OUT
#Oncoalert Reel by @oncoalert - Dear Colleagues at #GU26 OncoAlert🚨 is a proud Partner of @AUC3_Official Their Publication is NOW OUT ARTICLE HERE: 👉 https://acsjournals.onlinel
1.0K
ON
@oncoalert
Dear Colleagues at #GU26 OncoAlert🚨 is a proud Partner of @AUC3_Official Their Publication is NOW OUT ARTICLE HERE: 👉 https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70052?utm_campaign=buffer&utm_content=bufferce409&utm_medium=social&utm_source=twitter.com 3⃣Weeks ago We were in Sunny Miami🌴Learning from the TOP oncologists in #KidneyCancer and #BladderPractice . We had a chance to catch up with @DrChoueiri to tell us more about the publication and the meeting. @montyisapal @tiansterzhang @any_necchi @barbaramelao_urologia @drjosefernandomoura @natalia.gandur @kristina_jankovic @choueirit @neerajoncology @auc3_official
#Oncoalert Reel by @gog_foundation - Click link in bio or go to https://ow.ly/138N50YrqwF to view this on demand education today! #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #
227
GO
@gog_foundation
Click link in bio or go to https://ow.ly/138N50YrqwF to view this on demand education today! #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #clinicaltrials #GOGPartners #GOGF #clinicaltrials #endometrialcancer #IGCS2025

✨ #Oncoalert発見ガイド

Instagramには#Oncoalertの下にthousands of件の投稿があり、プラットフォームで最も活気のあるビジュアルエコシステムの1つを作り出しています。

ログインせずに最新の#Oncoalertコンテンツを発見しましょう。このタグの下で最も印象的なリール、特に@oncoalert, @onclive and @oncoassistからのものは、大きな注目を集めています。

#Oncoalertで何がトレンドですか？最も視聴されたReels動画とバイラルコンテンツが上部に掲載されています。

人気カテゴリー

📹 ビデオトレンド: 最新のReelsとバイラル動画を発見

📈 ハッシュタグ戦略: コンテンツのトレンドハッシュタグオプションを探索

🌟 注目のクリエイター: @oncoalert, @onclive, @oncoassistなどがコミュニティをリード

#Oncoalertについてのよくある質問

Pictameを使用すれば、Instagramにログインせずに#Oncoalertのすべてのリールと動画を閲覧できます。あなたの視聴活動は完全にプライベートです。ハッシュタグを検索して、トレンドコンテンツをすぐに探索開始できます。

パフォーマンス分析

12リールの分析

✅ 中程度の競争

💡 トップ投稿は平均2.9K回の再生（平均の2.2倍）

週3-5回、活動時間に定期的に投稿

コンテンツ作成のヒントと戦略

💡 トップコンテンツは1K+再生回数を獲得 - 最初の3秒に集中

✍️ ストーリー性のある詳細なキャプションが効果的 - 平均長532文字

📹 #Oncoalertには高品質な縦型動画（9:16）が最適 - 良い照明とクリアな音声を使用

#Oncoalert に関連する人気検索

🎬動画愛好家向け

Oncoalert ReelsOncoalert動画を見る

📈戦略探求者向け

Oncoalertトレンドハッシュタグ最高のOncoalertハッシュタグ

🌟もっと探索

Oncoalertを探索